The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
A Life Course Approach To Improving The Health And Well-being Of Young People With Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$193,360.00
Summary
Children with kidney disease suffers from profound ill-health and adopt a restrictive lifestyle, including dietary restriction, absences from school and other co-curricular activities. New knowledge and interventions are needed to address the pressing needs including of these children and their caregivers. This program of work will adopt a life-course approach to determine the protective and risk factors that affect the overall health and well-being of children with chronic kidney disease.
Evidence For Interventions That Improve Cardiovascular Outcomes In Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
The many Australians with kidney disease experience higher rates of cardiovascular events. Some of the highest rates of cardiovascular events and mortality are seen in people with kidney failure. Currently available treatments are inadequate at reducing this risk indicating an urgent need for new therapies. The program will investigate the effect of little used but readily available, promising interventions to assess their potential to reduce cardiovascular events for people with kidney disease.